Important Notice Regarding Oxervate

Posted in Latest News on January 24, 2020.

During the January 17, 2020 Board of Optometry meeting, the Board approved Oxervate (Cenergermin-bkbj) 0.002% for addition to Rule 64B13-18.002, Florida Administrative Code – Formulary of Topical Pharmaceutical Agents.

Important Note: At this time, Oxervate cannot be prescribed by Certified Optometrists in Florida until the rule has been approved. Once the rule has gone through the approval process, notice will be provided on the board website and both may be prescribed by Certified Optometrists at that time.



More Latest News

Notification of Renewal Deadline Extension
December 29, 2020

State Surgeon General Scott A. Rivkees issued Emergency Order 20-015 granting licensure renewal extensions
Continue reading


Potential Spam Alert
November 18, 2020

The Department of Health, Division of Medical Quality Assurance is warning Florida health care practitioners about fraudulent calls that have been received by multiple licensees.
Continue reading